Mushroom Wisdom - Super Chaga - 120 Vegetarian Tablets
Mushroom Wisdom Super Chaga contains 200 mg of pure Chaga extract. Maitake TD-Fraction and Vitamin C are added for additional immune enhancement.
Chaga (Inonotus obliquus) is a highly prized medicinal mushroom long used in traditional Russian medicine. Chaga research has demonstrated potent protective antioxidant and immune supporting actions. Super Chaga was developed by Dr. Zhuang, PhD, one of the original researchers of the Chaga mushroom. This concentrated extract utilizes a proprietary hot water extraction of wildcrafted Birch tree-grown Chaga sclerotium from Siberia.
Chaga (Inonotus obliquus)
A highly prized medicinal mushroom in traditional Russian medicine, Chaga came to the attention of the West when Nobel Prize winning Russian novelist Alexandr Solzhenitsyn introduced the birch tree mushroom and its beneficial properties in his 1968 novel, Cancer Ward. Chaga has demonstrated a variety of beneficial cardiovascular actions and immune supporting benefits, including activation of B cells and macrophage. It’s a Siberian secret - and now Mushroom Wisdom brings it to you.
About Mushroom Wisdom
Mushroom Wisdom, Inc. (formerly Maitake Products, Inc.) is a global leader in the development, production and research of medicinal mushroom supplements. The company introduced the Maitake mushroom to America in 1991. It is celebrating its 20th Anniversary during 2011.
Mushroom Wisdom brings the healthful benefits of medicinal mushrooms, backed by rigorous scientific research, to the daily routines of consumers worldwide. It offers a complete product line, including specific medicinal mushroom products developed to support the immune system, brain function, blood sugar levels, breast health, prostate health and more.
The company was founded in 1991 by President & CEO Mike Shirota. Its headquarters are in East Rutherford, New jersey.
Mushroom Wisdom Research
Mushroom Wisdom is a global leader in mycological research. The company supports clinical and laboratory studies involving Maitake D-Fraction, Maitake SX-Fraction, Lion's Mane and their active components. It has sponsored and/or been involved in scientific research in cooperation with prominent universities and medical centers, including:
- Memorial Sloan Kettering Caner Center
- National Cancer Institutes
- Cancer Treatment Centers of America
- Georgetown University
- New York Medical College
- Indiana School of Medicine
- Saga University (Japan)
- Shizuoka University (Japan)
- Showa University (Japan)
The company has received the IND (Investigational New Drug) approval from the FDA for its Pro Maitake D-Fraction (Tincture) for Phase II clinical studies on advanced breast and prostate cancer patients. It is exceptional for a dietary supplement company to be successful in obtaining IND approval for a dietary supplement product, since this has traditionally been regarded as a process by which giant pharmaceutical companies develop new drugs.